Expanded Access Program With Nivolumab to Treat Melanoma

NCT02142218 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Stage III (Unresectable) or Stage IV Advanced Melanoma

Interventions

DRUG: Nivolumab

Sponsor

Bristol-Myers Squibb